Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN

Summary: Fused in sarcoma/translated in liposarcoma (FUS) is a causative gene of amyotrophic lateral sclerosis (ALS). Mutated FUS causes accumulation of DNA damage and cytosolic stress granule (SG) formation, thereby motor neuron (MN) death. However, key molecular aetiology remains unclear. Here, we...

Full description

Bibliographic Details
Main Authors: Masahiro Nogami, Mitsuru Ishikawa, Atsushi Doi, Osamu Sano, Takefumi Sone, Tetsuya Akiyama, Masashi Aoki, Atsushi Nakanishi, Kazuhiro Ogi, Masato Yano, Hideyuki Okano
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996121001133
_version_ 1819105137976672256
author Masahiro Nogami
Mitsuru Ishikawa
Atsushi Doi
Osamu Sano
Takefumi Sone
Tetsuya Akiyama
Masashi Aoki
Atsushi Nakanishi
Kazuhiro Ogi
Masato Yano
Hideyuki Okano
author_facet Masahiro Nogami
Mitsuru Ishikawa
Atsushi Doi
Osamu Sano
Takefumi Sone
Tetsuya Akiyama
Masashi Aoki
Atsushi Nakanishi
Kazuhiro Ogi
Masato Yano
Hideyuki Okano
author_sort Masahiro Nogami
collection DOAJ
description Summary: Fused in sarcoma/translated in liposarcoma (FUS) is a causative gene of amyotrophic lateral sclerosis (ALS). Mutated FUS causes accumulation of DNA damage and cytosolic stress granule (SG) formation, thereby motor neuron (MN) death. However, key molecular aetiology remains unclear. Here, we applied a novel platform technology, iBRN, “Non- biased” Bayesian gene regulatory network analysis based on induced pluripotent stem cell (iPSC)-derived cell model, to elucidate the molecular aetiology using transcriptome of iPSC-derived MNs harboring FUSH517D. iBRN revealed “hub molecules”, which strongly influenced transcriptome network, such as miR-125b-5p-TIMELESS axis and PRKDC for the molecular aetiology. Next, we confirmed miR-125b-5p-TIMELESS axis in FUS H517D MNs such that miR-125b-5p regulated several DNA repair-related genes including TIMELESS. In addition, we validated both introduction of miR-125b-5p and knocking down of TIMELESS caused DNA damage in the cell culture model. Furthermore, PRKDC was strongly associated with FUS mis-localization into SGs by DNA damage under impaired DNA-PK activity. Collectively, our iBRN strategy provides the first compelling evidence to elucidate molecular aetiology in neurodegenerative diseases.
first_indexed 2024-12-22T02:17:28Z
format Article
id doaj.art-1410dd69c2fd495e97b6d914072ba267
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-22T02:17:28Z
publishDate 2021-07-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-1410dd69c2fd495e97b6d914072ba2672022-12-21T18:42:14ZengElsevierNeurobiology of Disease1095-953X2021-07-01155105364Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRNMasahiro Nogami0Mitsuru Ishikawa1Atsushi Doi2Osamu Sano3Takefumi Sone4Tetsuya Akiyama5Masashi Aoki6Atsushi Nakanishi7Kazuhiro Ogi8Masato Yano9Hideyuki Okano10Innovative Biology Laboratories, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa 251-8555, Japan; Shonan Incubation Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa 251-8555, Japan; Corresponding author at: Asia New Chemical Entity Production Laboratories, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa 251-8555, Japan.Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, JapanCell Innovator, Fukuoka 812-8582, JapanInnovative Biology Laboratories, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa 251-8555, JapanDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, JapanDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai 980-8574, JapanDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai 980-8574, JapanShonan Incubation Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa 251-8555, Japan; T-CiRA Discovery, Takeda Pharmaceutical Company Limited, Fujisawa 251-8555, JapanInnovative Biology Laboratories, Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa 251-8555, Japan; Shonan Incubation Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa 251-8555, JapanDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan; Division of Neurobiology and Anatomy, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, JapanDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan; Corresponding author.Summary: Fused in sarcoma/translated in liposarcoma (FUS) is a causative gene of amyotrophic lateral sclerosis (ALS). Mutated FUS causes accumulation of DNA damage and cytosolic stress granule (SG) formation, thereby motor neuron (MN) death. However, key molecular aetiology remains unclear. Here, we applied a novel platform technology, iBRN, “Non- biased” Bayesian gene regulatory network analysis based on induced pluripotent stem cell (iPSC)-derived cell model, to elucidate the molecular aetiology using transcriptome of iPSC-derived MNs harboring FUSH517D. iBRN revealed “hub molecules”, which strongly influenced transcriptome network, such as miR-125b-5p-TIMELESS axis and PRKDC for the molecular aetiology. Next, we confirmed miR-125b-5p-TIMELESS axis in FUS H517D MNs such that miR-125b-5p regulated several DNA repair-related genes including TIMELESS. In addition, we validated both introduction of miR-125b-5p and knocking down of TIMELESS caused DNA damage in the cell culture model. Furthermore, PRKDC was strongly associated with FUS mis-localization into SGs by DNA damage under impaired DNA-PK activity. Collectively, our iBRN strategy provides the first compelling evidence to elucidate molecular aetiology in neurodegenerative diseases.http://www.sciencedirect.com/science/article/pii/S0969996121001133Induced pluripotent stem cellBayesian gene regulatory network analysis based on iPSC-derived cell model (iBRN)Amyotrophic lateral sclerosis (ALS)Fused in sarcoma/translated in liposarcoma (FUS)DNA damage response (DDR)
spellingShingle Masahiro Nogami
Mitsuru Ishikawa
Atsushi Doi
Osamu Sano
Takefumi Sone
Tetsuya Akiyama
Masashi Aoki
Atsushi Nakanishi
Kazuhiro Ogi
Masato Yano
Hideyuki Okano
Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN
Neurobiology of Disease
Induced pluripotent stem cell
Bayesian gene regulatory network analysis based on iPSC-derived cell model (iBRN)
Amyotrophic lateral sclerosis (ALS)
Fused in sarcoma/translated in liposarcoma (FUS)
DNA damage response (DDR)
title Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN
title_full Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN
title_fullStr Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN
title_full_unstemmed Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN
title_short Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN
title_sort identification of hub molecules of fus als by bayesian gene regulatory network analysis of ipsc model ibrn
topic Induced pluripotent stem cell
Bayesian gene regulatory network analysis based on iPSC-derived cell model (iBRN)
Amyotrophic lateral sclerosis (ALS)
Fused in sarcoma/translated in liposarcoma (FUS)
DNA damage response (DDR)
url http://www.sciencedirect.com/science/article/pii/S0969996121001133
work_keys_str_mv AT masahironogami identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn
AT mitsuruishikawa identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn
AT atsushidoi identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn
AT osamusano identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn
AT takefumisone identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn
AT tetsuyaakiyama identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn
AT masashiaoki identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn
AT atsushinakanishi identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn
AT kazuhiroogi identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn
AT masatoyano identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn
AT hideyukiokano identificationofhubmoleculesoffusalsbybayesiangeneregulatorynetworkanalysisofipscmodelibrn